Cannara Biotech Stock Price, News & Analysis (OTCMKTS:CNBTF) $0.61 0.00 (0.00%) (As of 12/6/2023 ET) Add Share Share Today's Range$0.61▼$0.6150-Day Range$0.60▼$0.7652-Week Range$0.08▼$0.20VolumeN/AAverage Volume33,127 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines CNBTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CNBTF Stock News HeadlinesDecember 1, 2023 | cnbc.comWhy it's important to open a credit card at age 18December 1, 2023 | cnbc.comHere are the best virtual credit cards of 2023December 7, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 19, 2023 | cnbc.comDan BuettnerNovember 19, 2023 | cnbc.comPower LunchNovember 18, 2023 | cnbc.comMoney market account vs. High-yield savings account: What’s the difference and which one should you choose?October 8, 2023 | cnbc.comHugh SonOctober 1, 2023 | cnbc.comShares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill dataDecember 7, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comSeptember 27, 2023 | cnbc.comIf your business needs a revolving credit line, consider these 4 lendersSeptember 14, 2023 | cnbc.comLiz KnuevenSeptember 14, 2023 | cnbc.comElizabeth GravierSeptember 8, 2023 | cnbc.comJasmin SuknananSeptember 8, 2023 | cnbc.comLimited time offer: Get Walmart+ for 50% off and save shipping, gas and moreAugust 31, 2023 | cnbc.comBenji StawskiAugust 29, 2023 | cnbc.comPia SinghAugust 28, 2023 | cnbc.comWhat is a point-of-sale loan and are they worth it?August 12, 2023 | cnbc.comChina's Corporate Spy WarAugust 3, 2023 | cnbc.comCNBC's Last Call PodcastAugust 2, 2023 | cnbc.comTrump told by special counsel he is criminal target in Jan. 6 probeAugust 1, 2023 | cnbc.comThe best easy-to-earn credit card sign-up bonuses for low spendersJuly 29, 2023 | cnbc.comHow to use a microloan to help your small business growJuly 27, 2023 | benzinga.comCannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA?July 12, 2023 | cnbc.comMorgan ChittumJuly 12, 2023 | cnbc.comTaylor Swift, FTX and how investors can avoid potential scamsJune 30, 2023 | cnbc.comThis 51-year-old pays $725 a month to live in a 'tiny home on wheels’ in someone's backyard—take a look insideJune 30, 2023 | cnbc.comAri WeisbardSee More Headlines Receive CNBTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cannara Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry N/A Sub-IndustryN/A SectorN/A Current SymbolOTCMKTS:CNBTF CUSIPN/A CIKN/A Webcannara.ca PhoneN/AFaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Zohar Krivorot (Age 42)Founder, Pres, CEO & Director Mr. Lennie Ryer CPA (Age 58)CPA, CA, CFE, VP of Fin. & CFO Mr. Evan MorrisChief Operating OfficerMs. Julia BouvetChief of Staff CNBTF Stock Analysis - Frequently Asked Questions How have CNBTF shares performed in 2023? Cannara Biotech's stock was trading at $0.0733 at the beginning of the year. Since then, CNBTF shares have increased by 737.0% and is now trading at $0.6133. View the best growth stocks for 2023 here. How do I buy shares of Cannara Biotech? Shares of CNBTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:CNBTF) was last updated on 12/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cannara Biotech Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.